The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000180.4(GUCY2D):c.369C>T (p.Gly123=)

CA241302

195031 (ClinVar)

Gene: GUCY2D
Condition: GUCY2D-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: d3c44132-b64a-4505-b76b-0c38d144d384
Approved on: 2025-01-30
Published on: 2025-01-30

HGVS expressions

NM_000180.4:c.369C>T
NM_000180.4(GUCY2D):c.369C>T (p.Gly123=)
NC_000017.11:g.8003416C>T
CM000679.2:g.8003416C>T
NC_000017.10:g.7906734C>T
CM000679.1:g.7906734C>T
NC_000017.9:g.7847459C>T
NG_009092.1:g.5747C>T
ENST00000254854.5:c.369C>T
ENST00000254854.4:c.369C>T
NM_000180.3:c.369C>T
More

Benign

Met criteria codes 4
BS2_Supporting BS1 BP7 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GUCY2D Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
The NM_000180.4(GUCY2D):c.369C>T (p.Gly123=) variant is silent and occurs outside of the donor and acceptor splice regions. This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.001777, with 2088 alleles / 1133038 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA/eoRD VCEP BS1 threshold of >0.0016 (BS1). This variant has been found in the homozygous state in 4 adult individuals in gnomAD which exceeds the LCA/eoRD VCEP threshold of ≥3 (gnomAD v4.1.0; BS2_Supporting). The splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen LCA/eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4, BP7). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BS1, BS2_Supporting, BP4, BP7.(VCEP specifications version 1.0.0; date of approval 01/22/2025).
Met criteria codes
BS2_Supporting
This variant has been found in the homozygous state in 4 adult individuals in gnomAD which exceeds the LCA/eoRD VCEP threshold of ≥ 3 (gnomAD version 4.1.0; BS2_supporting).
BS1
This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.001777, with 2088 alleles / 1133038 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA / eoRD VCEP BS1 threshold of >0.0016 (BS1).
BP7
The splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4, BP7).
BP4
The splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.